In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CareX raises €25mm in Series B round

Executive Summary

CareX SA (studies gene expression to develop drugs for metabolic and cardiovascular diseases) closed its Series B round, raising €25mm ($32mm). New investor Index Ventures led the oversubscribed round, and was joined by other new backers Credit Lyonnais Private Equity, Global Life Science Ventures, and BioMedinvest, as well as returning participants Sofinnova Partners, GIMV, and Mara Venture Partners.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies